Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
URGN
#2067
UroGen Pharma Ltd. Ordinary Shares
21.700
0
+4.28%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+4.28%
Monthly Change
-0.60%
6 month change
+14.21%
Year Change
+14.21%
Previous Close
20.810
0
Open
21.700
0
Bid
Ask
Low
21.700
0
High
21.700
0
Volume
74
Markets
US Stock Market
Healthcare
URGN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
UroGen Pharma CMO Schoenberg sells $145k in shares
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
2025 Performance Review And Future Strategy
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Urogen Pharma stock hits 52-week high at 23.66 USD
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
UroGen Pharma stock jumps after positive Phase 3 trial results
UroGen Pharma stock price target raised to $30 from $25 at D. Boral Capital
Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates
UroGen Pharma earnings missed, revenue fell short of estimates
UroGen reports 77.8% response rate in bladder cancer drug trial